TAKEDA'S TETRAVALENT DENGUE VACCINE (TDV) CANDIDATE PROGRESSES TO PHASE III: SAFETY AND IMMUNOGENICITY OF TDV

被引：0
|
作者：
Wallace, Derek [1 ]
Tricou, Vianney [1 ]
Stinchcomb, Dan [2 ]
Amfo, Kwasi [1 ]
Borkowski, Astrid [3 ]
机构：
[1] Takeda Vaccines Pte Ltd, Singapore, Singapore
[2] Takeda Vaccines Inc, Deerfield, IL USA
[3] Takeda Pharmaceut Int AG, Zurich, Switzerland
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2017年 / 95卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
61
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [31] Post-authorization safety study (PASS): Cohort event monitoring for CYD-TDV dengue vaccine
    Cohen, Carine
    Marcelon, Lydie
    Moreira, Thais N. F.
    Lecciones, Julius
    Ann Bunyi, Mary
    Giamberardino, Heloisa I. G.
    Skipetrova, Anna
    Nealon, Joshua
    Sarti, Elsa
    Puentes-Rosas, Esteban
    Moureau, Annick
    Zocchetti, Celine
    Khromava, Alena
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 395 - 396
  • [32] Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study
    Sirivichayakul, Chukiat
    Barranco-Santana, Elizabeth A.
    Esquilin-Rivera, Ines
    Oh, Helen M. L.
    Raanan, Marsha
    Sariol, Carlos A.
    Shek, Lynette P.
    Simasathien, Sriluck
    Smith, Mary Kathryn
    Dario Velez, Ivan
    Wallace, Derek
    Gordon, Gilad S.
    Stinchcomb, Dan T.
    JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (10): : 1562 - 1572
  • [33] DISSECTING ANTIBODY RESPONSE INDUCED BY CHIMERIC YELLOW FEVER-DENGUE, LIVE- ATTENUATED, TETRAVALENT DENGUE VACCINE (CYD-TDV) TO UNDERSTAND VACCINE EFFICACY IN NAIVE AND DENGUE EXPOSED INDIVIDUALS
    Henein, Sandra
    Bonaparte, Matthew
    Baric, Ralph
    Swanstrom, Ar Jesica
    Byers, Tony
    Moser, Janice
    Guy, Bruno
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 424 - 424
  • [34] Dissecting Antibodies Induced by a Chimeric Yellow Fever-Dengue, Live-Attenuated, Tetravalent Dengue Vaccine (CYD-TDV) in Naive and Dengue-Exposed Individuals
    Henein, Sandra
    Swanstrom, Jesica
    Byers, Anthony M.
    Moser, Janice M.
    Shaik, S. Farzana
    Bonaparte, Matthew
    Jackson, Nicholas
    Guy, Bruno
    Baric, Ralph
    de Silva, Aravinda M.
    JOURNAL OF INFECTIOUS DISEASES, 2017, 215 (03): : 351 - 358
  • [35] Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003)
    Rivera, Luis
    Biswal, Shibadas
    Saez-Llorens, Xavier
    Reynales, Humberto
    Lopez-Medina, Eduardo
    Borja-Tabora, Charissa
    Bravo, Lulu
    Sirivichayakul, Chukiat
    Kosalaraksa, Pope
    Martinez Vargas, Luis
    Yu, Delia
    Watanaveeradej, Veerachai
    Espinoza, Felix
    Dietze, Reynaldo
    Fernando, LakKumar
    Wickramasinghe, Pujitha
    Duarte Moreira Jr, Edson
    Fernando, Asvini D.
    Gunasekera, Dulanie
    Luz, Kleber
    Venancioda Cunha, Rivaldo
    Rauscher, Martina
    Zent, Olaf
    Liu, Mengya
    Hoffman, Elaine
    LeFevre, Inge
    Tricou, Vianney
    Wallace, Derek
    Alera, Maria Theresa
    Borkowski, Astrid
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : 107 - 117
  • [36] Long-term Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Children and Adults: A Randomized, Placebo-Controlled, Phase 2 Study
    Sirivichayakul, Chukiat
    Barranco-Santana, Elizabeth A.
    Rivera, Ines Esquilin
    Kilbury, Jennifer
    Raanan, Marsha
    Borkowski, Astrid
    Papadimitriou, Athanasia
    Wallace, Derek
    JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (09): : 1513 - 1520
  • [37] Replication and Excretion of the Live Attenuated Tetravalent Dengue Vaccine CYD-TDV in a Flavivirus-Naive Adult Population: Assessment of Vaccine Viremia and Virus Shedding
    Torresi, Joseph
    Richmond, Peter C.
    Heron, Leon G.
    Qiao, Ming
    Marjason, Joanne
    Starr-Spires, Linda
    van der Vliet, Diane
    Jin, Jing
    Wartel, T. Anh
    Bouckenooghe, Alain
    JOURNAL OF INFECTIOUS DISEASES, 2017, 216 (07): : 834 - 841
  • [38] Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA
    Dayan, Gustavo H.
    Thakur, Manoj
    Boaz, Mark
    Johnson, Carol
    VACCINE, 2013, 31 (44) : 5047 - 5054
  • [39] Immunogenicity and Safety of a Tetravalent Recombinant Subunit Dengue Vaccine in Adults Previously Vaccinated with a Live Attenuated Tetravalent Dengue Vaccine: Results of a Phase-I Randomized Clinical Trial
    Durbin, Anna P.
    Pierce, Kristen K.
    Kirkpatrick, Beth D.
    Grier, Palmtama
    Sabundayo, Beulah P.
    He, Helen
    Sausser, Michele
    Russell, Amy Falk
    Martin, Jason
    Hyatt, Donna
    Cook, Melissa
    Sachs, Jeffrey R.
    Lee, Andrew Wen-Tseng
    Wang, Liman
    Coller, Beth-Ann
    Whitehead, Stephen S.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2020, 103 (02): : 855 - 863
  • [40] BRIDGING EFFICACY OF THE CYD-TDV TETRAVALENT DENGUE VACCINE FROM CHILDREN/ADOLESCENTS TO ADULTS IN HIGH ENDEMIC COUNTRIES BASED ON NEUTRALIZING ANTIBODY RESPONSE
    Gilbert, Peter B.
    Huang, Ying
    Juraska, Michal
    Moodie, Zoe
    Fong, Youyi
    Luedtke, Alexander
    Zhuang, Yingying
    Shao, Jason
    Carpp, Lindsay N.
    Jackson, Nicholas
    Chambonneau, Laurent
    Bouckenooghe, Alain
    Zambrano, Betzana
    Frago, Carina
    Pallardy, Sophie
    Noriega, Fernando
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 248 - 248
12345